Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
10/2005
10/26/2005CN1686166A Medicinal composition for treating blood vessel kind disease, its preparation process and its use
10/26/2005CN1224712C Vector
10/26/2005CN1224402C Use of Euproctis pseudoconspersa in preparing medicine for treating diseases of gastrointestinal tract
10/26/2005CN1224401C Beri-beri medicine powder
10/25/2005US6958386 MUM-1 protein expressed by multiple myeloma-related gene
10/25/2005US6958361 Drugs, vaccines
10/25/2005US6958158 Immune modulation device for use in animals
10/25/2005CA2390281C Hematopoietic differentiation of human embryonic stem cells
10/25/2005CA2251232C Method for gene transfer to the central nervous system
10/20/2005WO2005097995A1 CANCER THERAPY VIA THE INHIBITION OF Skp-2 EXPRESSION
10/20/2005WO2005097988A1 Bone marrow-relevant cell participating the maintenance and/or repair of tissue
10/20/2005WO2005097979A2 Methods and compositions for obtaining hematopoietic stem cells derived from embryonic stem cells and uses thereof
10/20/2005WO2005097976A1 Dendritic cell obtained by antigen pulsing
10/20/2005WO2005097974A2 Method for the production of a cell composition containing epithelial cells
10/20/2005WO2005097973A1 Compound ws 727713
10/20/2005WO2005097972A1 Medium for lactic acid bacteria
10/20/2005WO2005097262A1 A method of treatment for stroke employing administration of defibrinogenating agents to achieve a specific defibrinogenation pattern
10/20/2005WO2005097206A2 Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein a-i and apolipoprotein a-i milano
10/20/2005WO2005097170A1 Angiogenesis promoter and angiogenic therapy
10/20/2005WO2005097159A1 Ophthalmic preparation containing glycoprotein
10/20/2005WO2005097157A1 Ophthalmic preparation containing glycomacropeptide
10/20/2005WO2005097154A2 Neurotransmitter mixture which promotes the healing of wounds
10/20/2005WO2005097148A1 Pharmaceutics of traditional chinese medicine of treating aids and preparation method thereof
10/20/2005WO2005097147A1 Restenosis therapy using mesenchymal stem cells
10/20/2005WO2005097146A2 Dairy components effective for fat loss
10/20/2005WO2005097145A1 Myocarditis treatment
10/20/2005WO2005097143A1 Eye drops consisting of filtered clayey water for treating glaucoma
10/20/2005WO2005065396A3 Improved bone matrix compositions and methods
10/20/2005WO2005049844A3 Vectors, mutant viruses and methods for generating mutant viruses
10/20/2005WO2005030139A3 Seneca valley virus based compositions and methods for treating disease
10/20/2005WO2005009391A3 Antibiotic compound
10/20/2005WO2004064785A3 Cancer therapy sensitizer
10/20/2005US20050235371 Noval modified MSP-1 nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems
10/20/2005US20050234513 Implantable neuronal networks
10/20/2005US20050234089 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
10/20/2005US20050233992 Regeneration of endogeneous myocardial tissue by induction of neovascularization
10/20/2005US20050233983 Treatment of rumen acidosis with alpha-amylase inhibitors
10/20/2005US20050233967 Compositions, systems, and methods for focusing a cell-mediated immune response
10/20/2005US20050233956 Proteins involved in the regulation of energy homeostasis
10/20/2005US20050233453 6-O-sulfated N-acetylheparosan and hematopoietic stem cell growth auxiliary agent
10/20/2005US20050233452 Cell populations which co-express CD49c and CD90
10/20/2005US20050233451 Stimulating peripheral blood mononuclear cells in vitro with antigen, transducing with retroviral vector and reintroducing into patient
10/20/2005US20050233450 Methods of inducing hair growth
10/20/2005US20050233449 Simple and rapid derivation of functional hepatocytes from human bone marrow-derived mesenchymal stem cells
10/20/2005US20050233447 A cell simultaneously expressing albumin protein and a membrane-associated CD14 surface antigen; expresses a mRNA sequence typical of hepatocytes selected from the group consisting of alpha-fetoprotein, carbamyl phosphate synthetase I, coagulation factor II, and coagulation factor VII
10/20/2005US20050233446 Defined media for stem cell culture
10/20/2005US20050233443 Restenosis therapy using mesenchymal stem cells
10/20/2005US20050233301 Cryopreservation of haptenized tumor cells
10/20/2005US20050233300 Method for preserving sperm
10/20/2005US20050233004 Composition of Chinese drugs having neuro-protecting activity
10/20/2005US20050232950 Viruses comprising mutant ion channel protein
10/20/2005US20050232947 Bacterial spores
10/20/2005US20050232941 Compounds and methods for treatment and diagnosis of chlamydial infection
10/20/2005US20050232932 Compositions and methods for dendritic cell-based immunotherapy
10/20/2005US20050232909 Bacillus culture for use in prevention of bacterial infections
10/20/2005US20050232908 Novel use of the extract of processed ginseng and saponin isolated therefrom
10/20/2005US20050232907 Use of herpes vectors for tumor therapy
10/20/2005US20050232905 Use of peripheral blood cells for cardiac regeneration
10/20/2005US20050232904 Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance
10/20/2005US20050232903 Mincing tissue, culturing with growth factors, bone morphogenetic protein or vitamin D; propagating in alginate, agarose and collagen to form 3-dimensional structure
10/20/2005US20050232902 Injectable bioartificial tissue matrix
10/20/2005US20050232901 Materials and methods for treating or preventing oxalate-related disease
10/20/2005CA2592845A1 Eye drops consisting of filtered clayey water for treating glaucoma
10/20/2005CA2561645A1 A method of treatment for stroke employing administration of defibrinogenating agents to achieve a specific defibrinogenation pattern
10/19/2005EP1586634A1 Method of producing infectious reovirus
10/19/2005EP1586582A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
10/19/2005EP1586329A1 Botulinum toxin pharmaceutical compositions
10/19/2005EP1586326A1 Pharmaceutical compositions for treating neuronal damage and neurodegenerative diseases
10/19/2005EP1586284A1 Induction of immunological tolerance
10/19/2005EP1585556A1 Compositions comprising bone marrow cells, demineralized bone matrix and various site-reactive polymers for use in the induction of bone and cartilage formation
10/19/2005EP1585534A2 Composition comprising an extract of aphanizomenon flos-aquae, use thereof and preparation of same
10/19/2005EP1585426A2 Cell-seeded extracellular matrix grafts
10/19/2005EP1425297A4 Isolation of neural stem cells using gangliosides and other surface markers
10/19/2005EP1292340B1 Transfection system
10/19/2005EP1259251B1 Novel method for down-regulation of amyloid
10/19/2005EP1104482B1 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
10/19/2005EP1084278B1 Detection of dna, rna and proteins
10/19/2005EP1007631B1 Cardiac muscle regeneration using mesenchymal stem cells
10/19/2005EP0768894B1 Multi-stage cascade boosting vaccine
10/19/2005CN1685063A Methods and compositions relating to gene silencing
10/19/2005CN1685058A Peptides with anti-hypertensive properties
10/19/2005CN1684672A Dosage form having an inner core and at least two coating layers
10/19/2005CN1684589A Vascularization enhanced graft constructs
10/19/2005CN1683333A Method for using antural clarifying bacteriostat in organ extraction
10/19/2005CN1683299A Metabolites of ecteinascidin 743
10/19/2005CN1682981A Venom capsule for treating brain cancer
10/19/2005CN1682960A Gujinsa capsule and its preparing process
10/19/2005CN1682940A 黑膏 Black cream
10/19/2005CN1682771A Anti-tumor active matter and its preparing method and use
10/19/2005CN1682770A Process for preparing bee glue water solution and use
10/19/2005CN1682769A Trachyostracous mussel extract capable of increasing immunity function
10/19/2005CN1682768A Naoxinshu solid preparation good for brain and heart
10/19/2005CN1682767A Pearl powder soft capsule
10/19/2005CN1682766A Sperm agent and its derivative
10/19/2005CN1682765A Method for refining sheep placenta active component using membrane separating technology
10/19/2005CN1682764A Bone strengthening oral liquor and its preparing method
10/19/2005CN1682763A Method for extracting bone calcium from animal bone powder
10/19/2005CN1682762A Method for preparing visceral medicine
10/19/2005CN1682757A Method for removing heavy metal from mineral Chinese medicine
10/19/2005CN1223678C Pseudozoogloea particle adjuvant preparation and application
1 ... 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 ... 1259